Comparing the Efficacy of FMRI-Guided Vs. Standard ITBS in Treating Depression

NARecruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

September 16, 2024

Primary Completion Date

October 1, 2027

Study Completion Date

October 1, 2027

Conditions
DepressionDepressive Disorder, MajorDepressive Episode
Interventions
DEVICE

repetitive Transcranial Magnetic Stimulation

Repetitive transcranial magnetic stimulation (rTMS) is a Health Canada approved treatment for major depression. Typical treatments involve 30 to 45 minutes daily sessions delivered over 4 to 6 weeks. Recent technical advances allowed the development of theta burst stimulation (TBS), a novel rTMS paradigm that reduces daily sessions to 3 to 4 minutes while maintaining the same clinical efficacy. This study will specifically be administering intermittent TBS (iTBS), which is a novel refinement of conventional rTMS and consists of bursts of 3 stimulations at 50 Hz at theta frequency (5 Hz).

Trial Locations (1)

K1Z 7K4

RECRUITING

The Royal's Institute of Mental Health Research, Ottawa

All Listed Sponsors
lead

The Royal Ottawa Mental Health Centre

OTHER